Salt CompositionIpratropium 40mcg + Salbutamol 200mg
You Searched
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Chronic obstructive pulmonary disease (COPD)
Customers also bought
More About Ibires I 200mg/40mcg Nexcap
Benefits
In Chronic obstructive pulmonary disease (COPD) COPD (chronic obstructive pulmonary disease) is a group of lung diseases that cause breathing difficulties. COPD is caused by swelling of the airways that carry air in and out of the lungs. Ibires I 200mg/40mcg Nexcap relaxes the muscles of these airways and widens it. This makes you breathe easy and gives relief from symptoms such as tightness in your chest, shortness of breath, wheezing and coughing. Avoid smoking and minimise your exposure to pollution, dust and fumes. Along with that, a little exercise each day can help you stay strong. Talk to your doctor about how much exercise is good for you.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Do not chew, crush or break it. Do not swallow these capsules by mouth. These capsules are inhaled using a special inhaler, usually once daily as directed. Inhale 2 times per capsule to make sure you inhale all of the drug.
How it works
Ibires I 200mg/40mcg Nexcap is a combination of two medicines: Salbutamol and Ipratropium. Salbutamol is a bronchodilator while Ipratropium is an anticholinergic. They work by relaxing the muscles in the airways and widen the airways. Together, they make breathing easier.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Ibires I 200mg/40mcg Nexcap . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Ibires I 200mg/40mcg Nexcap may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Ibires I 200mg/40mcg Nexcap is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
No interaction found/established
No interaction found/established
No interaction found/established
What if I forget to take it?
If a dose of Ibires I 200mg/40mcg Nexcap is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Indiabulls Pharmaceuticals Limited is M ‚ 62 & 63, First Floor, Connaught Place, New Delhi ‚ 11000
References
Ipratropium bromide and albuterol sulfate. Ridgefield, Connecticut: Boehringer Ingelheim Pharmaceuticals, Inc.; 2008 (17 Apr. 2019)
Drugs.com. Ipratropium and Albuterol Inhalation Spray (17 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
